Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
03/2010
03/11/2010WO2010026208A1 1-aza-bicyclo[3.3.1]nonane or -3-ene derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
03/11/2010WO2010026177A1 1,4-diaza-bicyclo [3.2.2] nonyl pyridine derivatives as nicotinic and monoamine receptor modulators
03/11/2010WO2010026176A1 1,4 -diaza- bicyclo [3.2.2]n0nyl pyrimidine derivatives as nicotinic and monoamine receptor modulators
03/11/2010WO2010026134A1 Triazole derivatives and their use as nicotinic acetylcholine receptor modulators
03/11/2010WO2010026112A1 5-substituted benzoxazines
03/11/2010WO2010026104A1 4-tetrahydropyran-aminopyridine derivatives and their medical use
03/11/2010WO2010026087A1 Pyrazolyl-pyrimidine derivatives and their use as potassium channel modulators
03/11/2010WO2010026021A2 Combination of extracts of various plants for improving the symptoms of dementia disorders
03/11/2010WO2010025934A1 Pharmaceutical combination comprising 6-dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3-diol and an nsaid
03/11/2010WO2010025931A2 Pharmaceutical combination
03/11/2010WO2010025930A1 Pharmaceutical combination comprising 6-dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3 diol and paracetamol
03/11/2010WO2010025890A1 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
03/11/2010WO2010025589A1 Long acting curcumine derivates and preparation method thereof
03/11/2010WO2010025510A1 Libraries of peptide conjugates and methods for making them
03/11/2010WO2009148290A3 3-substituted propanamine compounds
03/11/2010WO2009143507A3 Silent desensitizers of neuronal nachr and methods of use thereof
03/11/2010WO2009141736A3 Inhibition of emmprin to treat multiple sclerosis
03/11/2010WO2009139589A3 Transnasal anticonvulsive pharmaceutical composition comprising poorly soluble anticonvulsant
03/11/2010WO2009137843A9 Nmda receptor antagonists for the treatment of neuropsychiatric disorders
03/11/2010WO2009120580A3 Methods for preventing or treating bruxism using dopaminergic
03/11/2010WO2009080818A3 Guanidine based compounds
03/11/2010WO2009071947A3 Potassium ion channel modulators and uses thereof
03/11/2010WO2009071912A3 Material comprising nm23 linked to a substrate for use in treating neuron disorders
03/11/2010WO2009004038A8 Pirenzepine and derivatives thereof as anti-amyloid agents
03/11/2010US20100063161 Treatment of pervasive developmental disorders with redox-active therapeutics
03/11/2010US20100063160 Polymorphs of o-desmethyl venlafaxine succinate
03/11/2010US20100063158 Crystalline form III of agomelatine, a process for its preparation and pharmaceutical compositions containing it
03/11/2010US20100063148 Antiepileptic agent in combination with tapentadol; use treating pain including cancer pain and neuropathic pain; synergistic
03/11/2010US20100063147 Anaplerotic Therapy of Huntington Disease and Other Polyglutamine Diseases
03/11/2010US20100063144 Compounds and uses thereof
03/11/2010US20100063142 o/w/o EMULSION CONTAINING LIGNAN COMPOUNDS AND COMPOSITION CONTAINING THE SAME
03/11/2010US20100063138 Novel substituted sulfamide derivatives
03/11/2010US20100063134 comprising the steps of surgically implanting a catheter ; without impairment of cell endoplasmic reticulum, spontaneous motor activity, or locomotor activity; Alzheimer's, Parkinson's, Huntington's diseases, Spinocerebellar Ataxia Type 1, Type 2, Type 3, and/or dentatorubral-pallidoluysian atrophy
03/11/2010US20100063116 Use of pramipexole or a salt thereof for the treatment of parkinson's disease
03/11/2010US20100063098 Pyridone derivatives as p38a mapk inhibitors
03/11/2010US20100063097 Azabicyclo [3.1.0] Hexane Derivatives as Modulators of Dopamine D3 Receptors
03/11/2010US20100063093 Methods for the administration of iloperidone
03/11/2010US20100063092 3-cyano-4-(4-phenyl-piperidin-1-yl)-pyridin-2-one derivatives
03/11/2010US20100063089 Succinate salt of 2-((4-(1-methyl-4-pyridin-4-yl)-1h-pyrazol-3-yl)phenoxy)methyl)quinoline
03/11/2010US20100063086 Pharmaceutical compounds
03/11/2010US20100063085 Method of treating learning impairment in down's syndrome subjects
03/11/2010US20100063084 Multi-phase release methscopolamine compositions
03/11/2010US20100063079 Pyrimidyl Sulphone Amide Derivatives as Chemokine Receptor Modulators
03/11/2010US20100063078 Spirocompounds useful as modulators for dopamine d3 receptors
03/11/2010US20100063077 Pyrimidine derivatives for the treatment of amyloid-related diseases
03/11/2010US20100063070 Combination for use in the treatment of inflammatory disorders
03/11/2010US20100063065 Thiophene derivatives as ppar agonists i
03/11/2010US20100063062 Novel use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts
03/11/2010US20100063058 4-alkoxypyridazine derivatives as fast dissociating dopamine 2 receptor antagonists
03/11/2010US20100063055 Condensed tetrahydroquinoline derivative and use thereof for medical purposes
03/11/2010US20100063050 Novel heteropyrrole analogs acting on cannabinoid receptors
03/11/2010US20100063044 Substituted aniline derivatives
03/11/2010US20100063043 Substituted 2-oxo-3-phenyl-5-carbonylaminomethyl-1, 3-oxazolines and their use as anticoagulant and antithrombotics
03/11/2010US20100063036 Substituted morpholine and thiomorpholine derivatives
03/11/2010US20100063034 Conjugated psychotropic drugs and uses thereof
03/11/2010US20100063033 administering (2,6-Dimethyl-4-morpholin-4-yl-phenyl)-carbamic acid butyl ester, for the treatment of bipolar disorders, seizure disorders, anxiety disorders, neuropathic pain and migraine pain disorders or neurodegenerative disorders
03/11/2010US20100063032 Substituted pyrido[2,3-d]pyrimidine derivatives as cannabinoid-1 receptor modulators
03/11/2010US20100063030 Benzenesulfonyl Compounds and the Use Thereof
03/11/2010US20100063029 Use of s-10-hydroxy-10,11-dihydro-carbamazepine for the treatment of anxiety and bipolar disorders
03/11/2010US20100063028 Triazabenzo[E]Azulene Derivatives for the Treatment Of Tumors
03/11/2010US20100063025 Substituted isoquinoline and isoquinolinone derivatives as inhibitors of RHO-Kinase
03/11/2010US20100063022 Novel compounds as cannabinoid receptor ligands
03/11/2010US20100063010 Method for administering a spill resistant pharmaceutical system
03/11/2010US20100063009 Pharmaceutical Combination Comprising 6-Dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1.3-diol and an NSAID
03/11/2010US20100063004 Topical pharmaceutical composition
03/11/2010US20100063002 Method of improving skills with a composition comprising non-digestible saccharide
03/11/2010US20100062998 Prevention and/or Treatment of Neurodegenerative Disorders
03/11/2010US20100062991 Novel 1,4-benzothiepin-1,1-dioxide derivatives which are substituted with fluorine, method for producing the same, drugs containing said compounds and use thereof
03/11/2010US20100062989 OPTIMAL BIOLOGICAL MARKER FOR THE BIOLOGICAL POTENCY OF Emblica Officinalis Gaertn. (AMLA) FRUIT-METHODS AND PRODUCTS THEREOF
03/11/2010US20100062988 Chewable sustained release formulations
03/11/2010US20100062987 Anticonvulsive pharmaceutical compositions
03/11/2010US20100062087 Nutraceutical Treatments for Diabetic and Non-Diabetic Wound Healing
03/11/2010US20100062082 Ion sensor for fluid and method for its manufacture
03/11/2010US20100062081 Use of tellurium containing compounds as nerve protecting agents
03/11/2010US20100062077 Pyrrolo[1,2-a]imidazoledione effective in the treatment of peripheral neurotoxicity induced by chemotherapeutic agents
03/11/2010US20100062060 Pharmaceutical composition comprising tramadol and ketoprofen in association
03/11/2010US20100062045 Method for suppressing coloring of adhesive prepartion containing donepezil and method for reducing amounts of donepezil-related substances formed
03/11/2010US20100062037 Subcutaneous implants releasing an active principle over an extended period of time
03/11/2010US20100062024 Biologically Active Hemagglutinin From Type A Clostridium Botulinum and Methods of Use
03/11/2010US20100062011 Peptide Vaccine for Inducing the Production of Anti-Amyloid ß-Peptide Antibody
03/11/2010US20100061994 Medical uses of 39-desmethoxyrapamycin and analogues thereof
03/11/2010US20100061993 Antibodies
03/11/2010US20100061935 Methods of using sustained release aminopyridine compositions
03/11/2010CA2739209A1 Use of 3,11b-cis-dihydrobenazine in the treatment of dementia and associated cognitive deficit
03/11/2010CA2739201A1 Pharmaceutical compounds
03/11/2010CA2736767A1 N-sulfonamido polycyclic pyrazolyl compounds
03/11/2010CA2736304A1 Pyrazolopyrimidines and their use for the treatment of cns disorders
03/11/2010CA2736281A1 Tri-substituted pyrimidine compounds and their use as pde10 inhibitors
03/11/2010CA2736187A1 Novel compositions and adjuvants
03/11/2010CA2736114A1 Treatment of neurological disorders using huperzine
03/11/2010CA2735970A1 Isatin derivatives for use as in vivo imaging agents
03/11/2010CA2735934A1 Method of treatment of attention deficit/hyperactivity disorder (adhd)
03/11/2010CA2735857A1 Pharmaceutical combination of 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol and an antiepileptic
03/11/2010CA2735855A1 Pharmaceutical combination comprising 6-dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3-diol and paracetamol
03/11/2010CA2735806A1 Aminotriazolopyridines and their use as kinase inhibitors
03/11/2010CA2735775A1 6-substituted benzoxazines
03/11/2010CA2735773A1 Triazole derivatives and their use as nicotinic acetylcholine receptor modulators
03/11/2010CA2735764A1 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
03/11/2010CA2735139A1 Pharmaceutical combination comprising 6-dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3-diol and an nsaid
03/11/2010CA2734500A1 Compounds that modulate intracellular calcium
1 ... 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 ... 1833